Evidence map›Paper›PMID 17626635›Full record

ArticleBMC cancer2007

Overexpressed TP73 induces apoptosis in medulloblastoma.

Robert C Castellino, Massimiliano De Bortoli, Linda L Lin, Darlene G Skapura, Jessen A Rajan, Adekunle M Adesina, Laszlo Perlaky, Meredith S Irwin, John Y H Kim

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Dichotomous transactivation domains contribute to growth inhibitory and promotion functions of TAp73.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Clinical implications of the deregulated TP73 isoforms expression in cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Robert C CastellinoTexas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA. Craig_Castellino@oz.ped.emory.edu <Craig_Castellino@oz.ped.emory.edu>
Massimiliano De Bortoli
Linda L Lin
Darlene G Skapura
Jessen A Rajan
Adekunle M Adesina
Laszlo Perlaky
Meredith S Irwin
John Y H Kim
Baylor College of Medicine · USChildren's Cancer Center · USUniversity of Toronto · CA

Funding

Baylor Research Training Program for PediatriciansT32HD042977 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI FEIGIN, RALPH DAVID · 2003 to 2007
$1.1M
TRKC-INDUCED APOPTOSIS IN PTC+/- MOUSE MEDULLOBLASTOMAK08NS043517 · NINDS · DANA-FARBER CANCER INSTITUTE · PI KIM, JOHN Y · 2001 to 2005
$635k
NICHD NIH HHS HD042977NICHD NIH HHS T32 HD042977NINDS NIH HHS K08 NS043517NINDS NIH HHS NS043517
6 · The paper itself

Abstract

backgroundMedulloblastoma is the most common malignant brain tumor of childhood. Children who relapse usually die of their disease, which reflects resistance to radiation and/or chemotherapy. Improvements in outcome require a better understanding of the molecular basis of medulloblastoma growth and treatment response. TP73 is a member of the TP53 tumor suppressor gene family that has been found to be overexpressed in a variety of tumors and mediates apoptotic responses to genotoxic stress. In this study, we assessed expression of TP73 RNA species in patient tumor specimens and in medulloblastoma cell lines, and manipulated expression of full-length TAp73 and amino-terminal truncated DeltaNp73 to assess their effects on growth.

methodsWe analyzed medulloblastoma samples from thirty-four pediatric patients and the established medulloblastoma cell lines, Daoy and D283MED, for expression of TP73 RNA including the full-length transcript and the 5'-terminal variants that encode the DeltaNp73 isoform, as well as TP53 RNA using quantitative real time-RTPCR. Protein expression of TAp73 and DeltaNp73 was quantitated with immunoblotting methods. Clinical outcome was analyzed based on TP73 RNA and p53 protein expression. To determine effects of overexpression or knock-down of TAp73 and DeltaNp73 on cell cycle and apoptosis, we analyzed transiently transfected medulloblastoma cell lines with flow cytometric and TUNEL methods.

resultsPatient medulloblastoma samples and cell lines expressed full-length and 5'-terminal variant TP73 RNA species in 100-fold excess compared to non-neoplastic brain controls. Western immunoblot analysis confirmed their elevated levels of TAp73 and amino-terminal truncated DeltaNp73 proteins. Kaplan-Meier analysis revealed trends toward favorable overall and progression-free survival of patients whose tumors display TAp73 RNA overexpression. Overexpression of TAp73 or DeltaNp73 induced apoptosis under basal growth conditions in vitro and sensitized them to cell death in response to chemotherapeutic agents.

conclusionThese results indicate that primary medulloblastomas express significant levels of TP73 isoforms, and suggest that they can modulate the survival and genotoxic responsiveness of medulloblastomas cells.

Indexed as

Gene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorBlotting, WesternCell Line, TumorCell SurvivalCerebellar NeoplasmsChildChild, PreschoolDisease ProgressionDNA-Binding ProteinsFlow CytometryFollow-Up StudiesGene SilencingHumansImmunohistochemistryBiomarkers, TumorDNA-Binding ProteinsNuclear ProteinsRNA, NeoplasmTumor Suppressor Proteins

Identifiers

PMID17626635
PMCPMC1955450
OpenAlexW2053326267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.